Keywords
Coronavirus
Stroke
Risk
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To establish the main risk factors associated with the development of stroke during acute cases of COVID-19. Methods: This is a integrative bibliographical research, descriptive and explanatory in nature. Conducting the study with the guiding question: Which factors are associated with the development of stroke in patients with acute COVID-19? The literature search was carried out in the LILACS, MEDLINE and IBECS databases, using the descriptors stroke, stroke, Coronavirus, COVID-19, Prognosis, Risk. Results: 15 relevant articles were included, which showed an average incidence of 1.69%, most cases were male (>53%), aged over 60 years, black (47%), comorbidities most commonly found were hypertension, hyperlipidemia and DM, as well as an increase in D-dimer and CRP values. Final considerations: The average incidence of stroke during COVID-19 was approximately 1.69%, presenting significant morbidity and mortality. It was observed that advanced age (>60 years), male sex, black race and presence of comorbidities (mainly hypertension and DM) appear to be significant predictors for the development of stroke in cases of COVID-19.
References
ALMEIDA JO, et al. COVID-19: Fisiopatologia e Alvos para Intervenção Terapêutica. Rev. Virtual Quim., 2020; 16(6): 1464-1497.
ALOTAIBI BA, et al. The Risk Factors for Acute Cerebrovascular Accident (Stroke) in Patients with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Viruses, 2023; 15(5): 1140.
ALVES CL, et al. Acidente Vascular Encefálico em adultos jovens com ênfase nos fatores de risco. Revista Brasileira Interdisciplinar de Saúde, 2020; 2(1).
ALVES LF, et al. Aspectos do AVE isquêmico: uma revisão bibliográfica. Brazilian Journal of Health Review, 2022; 5(2): 4098-4113.
CUI Y, et al. Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis. Brain Res Bull, 2022; 180: 31-37.
FATIMA N, et al. Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic. Neurological Sciences, 2020; 41: 2675-2679.
GOYAL N, et al. Do elevated levels of inflammatory biomarkers predict the risk of occurrence of ischemic stroke in SARS-CoV2? an observational study. Journal of Stroke and Cerebrovascular Diseases, 2021; 30(11): 106063.
JAMORA RDG, et al. Incidence and risk factors for stroke in patients with COVID-19 in the Philippines: An analysis of 10,881 cases. J Stroke Cerebrovasc Dis, 2022; 31(11): 106776.
LEKOUBOU A, et al. Racial Disparities in Ischemic Stroke Among Patients with COVID-19 in the United States. J Stroke Cerebrovasc Dis, 2021; 30(8): 105877.
LUO W, et al. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol, 2022; 269(4): 1731-1740.
MENDES KDS, et al. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto – Enfermagem, 2008; 17(4): 758–764.
PECLY IMD, et al. Uma revisão da Covid-19 e lesão renal aguda: da fisiopatologia aos resultados clínicos. J. Bras. Nefrol, 2021; 43(4): 551–571.
REQUENA M, et al. COVID-19 and stroke: incidence and etiological description in a high-volume center. Journal of Stroke and Cerebrovascular Diseases, 2020; 29(11): 105225.
SADEGHMOUSAVI S e REZAEI N. COVID-19 infection and stroke risk. Rev. Neurosci, 2021; 32(3): 341-349.
SHAHRAM A, et al. Call to action: SARS-CoV-2 and cerebrovascular disorders (CASCADE). J Stroke Cerebrovasc Dis, 2020; 29(9): 104938.
SIOW I, et al. Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors. Journal of Stroke and Cerebrovascular Diseases, 2021; 30(3): 105549.
SLUIS WM, et al. Risk, clinical course, and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study. Stroke, 2021; 52(12): 3978-3986.
SOUZA ASR, et al. Aspectos gerais da pandemia de COVID-19. Revista Brasileira de Saúde Materno Infantil, 2021; 21: 29–45.
TAN Y, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. Journal of thrombosis and thrombolysis, 2020; 50: 587-595.
TOPCUOGLU MA, et al. Stroke mechanism in COVID-19 infection: a prospective case-control study. Journal of Stroke and Cerebrovascular Diseases, 2021; 30(8): 105919.
TRIFAN G, et al. Characteristics of a diverse cohort of stroke patients with SARS-CoV-2 and outcome by sex. Journal of Stroke and Cerebrovascular Diseases, 2020; 29(11): 105314.
VIDALE S. Risk factors, and clinical and etiological characteristics of ischemic strokes in COVID-19-infected patients: a systematic review of literature. Cerebrovascular Diseases, 2021; 50(4): 371-374.
YAMAKAWA M, et al. Clinical characteristics of stroke with COVID-19: a systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases, 2020; 29(12): 105288.
YAO X, et al. The clinical characteristics and prognosis of COVID-19 patients with cerebral stroke: A retrospective study of 113 cases from one single-centre. Eur J Neurosci, 2021; 53(4): 1350-1361.
ZHANG L, et al. Clinical course and mortality of stroke patients with coronavirus disease 2019 in Wuhan, China. Stroke, 2020; 51(9): 2674-2682.